Trial Profile
A Phase 2, Open-Label Study of HTX 011 in a Multimodal Analgesic Regimen for Decreased Opioid Use Following Unilateral Open Inguinal Herniorrhaphy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 Oct 2021
Price :
$35
*
At a glance
- Drugs Bupivacaine/meloxicam (Primary) ; Ibuprofen; Ketorolac; Paracetamol
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Heron Therapeutics
- 16 Sep 2020 According to a Heron Therapeutics media release, results have been published online by the journal, Surgery.
- 16 Sep 2020 Results published in Heron Therapeutics Media Release
- 12 Mar 2019 Status changed from recruiting to completed.